Close Menu

The announcement earlier this week that Pfizer and BioNTech's SARS-CoV-2 vaccine appears effective may bode well for other, similar vaccines, the Verge reports

"It's extremely encouraging, in my view, not only for the Pfizer vaccine, but broadly speaking for the platform," the University of Colorado's Ross Kedl tells it.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A Harvard-led team reprogrammed DNA methylation patterns of mice with eye problems to restore their sight, AFP reports.

A man in India is suing the Serum Institute of India, saying that he suffered serious side effects from a vaccine it is testing, but the institute has rejected those claims, the Economic Times reports.

The New York Times reports Moderna is planning a clinical trial of its SARS-CoV-2 vaccine in children.

In Nature this week: Readfish tool for targeted nanopore sequencing, genomic diversity of barley and wheat, and more.